ONCY Oncolytics Biotech, Inc.: מכפיל שווי פעילות להכנסות

Oncolytics (ONCY) - לוגו תאגידי

Oncolytics Biotech Inc. (ONCY) is developing viral platforms through partnerships with industry behemoths to accelerate therapy testing. The EV/Sales ratio on the GURU.Markets daily chart reflects valuation dynamics, where the value 0.00 captures the metric level. Oncolytics Biotech Inc. (ONCY) is implementing energy-saving technologies in biomanufacturing and scaling breast cancer treatment for FDA registration.

Oncolytics Biotech - יחס שווי פעילות להכנסות ONCY (תקופה 23.11.2025 - 20.11.2026)

ONCY (Oncolytics): פילוחים אנליטיים ודוחות לפי אינדיקטורים

- ציטוטים ותחזית אנליסטים:
ניתוח ראשוני של החברה:Oncolytics Biotech, Inc., ONCY
מוצר מקורי של Oncolytics Biotech, Inc.

Accurate business valuation is critical for identifying fundamental sector leaders. This indicator compares the total enterprise value with annual revenue, neutralizing the impact of debt load. For Oncolytics Biotech Inc. (ONCY), this metric reflects market demand for innovation amid a reliance on external contract laboratories. Effective management of medical protocols directly impacts investment attractiveness. By analyzing the EV/Sales ratio trend, an investor determines the degree to which the asset is overbought.